Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis C

Free Subscription 30.01.2023 1 J Hepatol 1 J Viral Hepat 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Hepatol

1. MAALEJ NH, Collins IJ, Ades AE, Scott K, et al
   Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.
   J Hepatol. 2023 Jan 17:S0168-8278(23)00014-4. doi: 10.1016/j.jhep.2022.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

2. TERRAULT NA, Slepin J, Kanner R, Gailloux K, et al
   Strategies to Increase Primary Care Provider Capacity for Hepatitis C Care: The California ECHO-PLUS Study.
   J Viral Hepat. 2023 Jan 25. doi: 10.1111/jvh.13807.
   PubMed         Abstract available
   
   

   
   PLoS One

3. STEINBRINK JM, Miller C, Myers RA, Sanoff S, et al
   Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naive recipients of HCV-infected donor kidneys.
   PLoS One. 2023;18:e0280602.
   PubMed         Abstract available
   
   
4. DAVITKOV P, Hoffman K, Falck-Ytter Y, Wilson B, et al
   Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A population-based study.
   PLoS One. 2023;18:e0280647.
   PubMed         Abstract available
   
   
5. AMBAYE E, Ormago MD, Ali MM
   Sero-prevalence and associated factors of sexually transmitted infections among youth-friendly services Attendees.
   PLoS One. 2023;18:e0279900.
   PubMed         Abstract available
   
   
6. SY A, McCabe L, Hudson E, Ansari AM, et al
   Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.
   PLoS One. 2023;18:e0280551.
   PubMed         Abstract available
   
   
7. WONG WB, Seetasith A, Hung A, Zullig LL, et al
   Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs.
   PLoS One. 2023;18:e0280570.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: